RecruitingPhase 2NCT06311955

Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor

Studying Thymic epithelial neoplasm

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Jian Chen
Principal Investigator: Jingfang Mao, PHD
Shanghai Proton and Heavy Ion Center
Intervention: Carbon ion radiotherapy(radiation)
Enrollment: 48 enrolled
Eligibility: 18-70 years · All sexes
Timeline: 2025 – 2029

Study locations (1)

Shanghai Proton and Heavy Ion Center, Shanghai, Shanghai Municipality, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06311955 on ClinicalTrials.gov

Other trials for Thymic epithelial neoplasm

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT05558644
Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET)
Institut Curie

See all trials for Thymic epithelial neoplasm →

← Back to all trials